SOLARA vs VINEETLAB: Stock Comparison

SOLARA ACTIVE PHA SCI vs VINEET LABORATORIESUpdated 11 Sept 26, 4:08 PM ISTNSE & company filings

SOLARA ACTIVE PHA SCI is the larger company by market capitalisation. SOLARA ACTIVE PHA SCI shows a higher ROE, faster revenue growth and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

SOLARA leads 9; VINEETLAB leads 0 of 11

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

SOLARAVINEETLAB

Valuation lens

What price are you paying?

Market CapContext only
₹3,628 Cr
₹72 Cr
P/E RatioSame reading
0x
P/B RatioSame reading
2.89x
EPSSOLARA has the higher reading
₹3.52
₹0.63
Book ValueContext only
₹260.24
₹23.74
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
SOLARA is the larger company
₹3,628 Cr vs ₹72 Cr
EPS
SOLARA has higher earnings per share
₹3.52 vs ₹0.63
Revenue Growth (TTM YoY)
SOLARA has faster revenue growth
41.9% vs 11.05%
Qtr Sales Growth
SOLARA has stronger quarterly sales growth
0% vs -68.2%
Qtr Profit Growth
SOLARA has stronger quarterly profit growth
4.17% vs -24.05%
ROE
SOLARA has a higher ROE
-0.59% vs -69.22%
ROCE
SOLARA has a higher ROCE
4.56% vs -11.29%
Net Margin
SOLARA has a higher net margin
-0.54% vs -26.92%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricSOLARAVINEETLAB
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricSOLARAVINEETLAB
Live Price₹749.15₹37.02
Day Change5.92%3.44%
Volume11.6 L71,650
52-Week High₹749.8₹49.99
52-Week Low₹422₹27.96
Distance from 52W High-0.09%-25.95%

Valuation

MetricSOLARAVINEETLAB
Market Cap₹3,628 Cr₹72 Cr
P/E Ratio0x
P/B Ratio2.89x
EPS₹3.52₹0.63
Book Value₹260.24₹23.74
Dividend Yield0%0%

Growth

MetricSOLARAVINEETLAB
Revenue Growth (TTM YoY)41.9%11.05%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth0%-68.2%
Qtr Profit Growth4.17%-24.05%

Profitability & Leverage

MetricSOLARAVINEETLAB
ROE-0.59%-69.22%
ROCE4.56%-11.29%
Net Margin-0.54%-26.92%
Operating Margin6.38%-11.25%
Debt to Equity0.53x2.73x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricSOLARAVINEETLAB
Promoter Holding41.93% 0.07 pp5.98%
FII Holding11.52% 0.19 pp0.5% 0.14 pp
DII Holding3.74% 0.04 pp
Public Holding42.81% 0.08 pp93.52% 0.14 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: SOLARA ACTIVE PHA SCI and VINEET LABORATORIES.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.